Use of histone deacetylase inhibitors (HDACis) in pancreatic ductal adenocarcinoma (PDAC): A narrative review
et
12 juil. 2025
À propos de cet article
Catégorie d'article: Research Article
Publié en ligne: 12 juil. 2025
Reçu: 06 oct. 2024
Accepté: 23 déc. 2024
DOI: https://doi.org/10.2478/fco-2024-0007
Mots clés
© 2025 Vassiliki Tarara et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Tarara, Vassiliki
Laboratory of Histology and Embryology, Aristotle University of Thessaloniki, School of MedicineThessaloniki, Greece
Karamitrousis, Evangelos
Medical Oncology Department, School of Medicine, Aristotle University of Thessaloniki, Papageorgiou General HospitalThessaloniki, Greece